Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Trianni, Inc. and Simon Fraser University Announce Licensing Agreement for The Trianni Mouse™

Trianni,Inc.
Posted on: 18 Sep 18
Trianni, Inc. and Simon Fraser University Announce Licensing Agreement for The Trianni Mouse™

PR Newswire

SAN FRANCISCO, Sept. 18, 2018

SAN FRANCISCO, Sept. 18, 2018 /PRNewswire/ -- Trianni, Inc. ("TRIANNI") and Simon Fraser University ("SFU") announced today that SFU has entered into a license agreement for The Trianni Mouse™, a best-in-class human monoclonal antibody discovery platform. The platform, which incorporates a complete human antibody repertoire, will be used to support vaccine research and development efforts led by Dr. Ralph Pantophlet, an Associate Professor in the Faculty of Health Sciences at SFU and a Michael Smith Foundation for Health Research Scholar.

"We look forward to utilizing Trianni's technological platform to advance our vaccine research endeavors even further," said Dr. Pantophlet.

"We at TRIANNI are excited to partner with Dr. Pantophlet and support his vaccine research at SFU," stated Matthias Wabl, Ph.D., TRIANNI's President & Chief Executive Officer. "We look forward to Dr. Pantophlet team's success with The Trianni Mouse."

No financial details were disclosed.

About Trianni, Inc.
Trianni, Inc. is a privately held biotech company specializing in antibody discovery technology. TRIANNI's lead technology, The Trianni Mouse™, is a powerful, next-generation platform enabling efficient generation of fully-human monoclonal antibodies. TRIANNI's transgenic platform leverages a novel approach to design made possible by advances in DNA synthesis and genomic modification technology, making it a best-in-class therapeutic antibody discovery platform.  The company is headquartered in San Francisco, CA. Additional information about TRIANNI is available through its corporate website, www.trianni.com.

About Simon Fraser University
As Canada's engaged university, SFU is defined by its dynamic integration of innovative education, cutting-edge research and far-reaching community engagement. SFU was founded more than 50 years ago with a mission to be a different kind of university—to bring an interdisciplinary approach to learning, embrace bold initiatives, and engage with communities near and far. Today, SFU is Canada's leading comprehensive research university and is ranked one of the top universities in the world. With campuses in British Columbia's three largest cities—Vancouver, Burnaby and Surrey—SFU has eight faculties, delivers almost 150 programs to over 35,000 students, and boasts more than 145,000 alumni in 130 countries around the world.

Contacts: Trianni, Inc
Mandy Boyd
Director of Marketing
1.415.231.0256 [o]
1.866.674.9314
mandy.boyd@trianni.com       

Contacts: SFU
Ralph Pantophlet
Associate Professor, Faculty of Health Sciences
Tel: 1.778.782.8648
Email: rpantophlet@sfu.ca

View original content to download multimedia:http://www.prnewswire.com/news-releases/trianni-inc-and-simon-fraser-university-announce-licensing-agreement-for-the-trianni-mouse-300714267.html

SOURCE Trianni, Inc.

PR Newswire
www.prnewswire.com

Last updated on: 18/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.